Bioregenx (BRGX) Equity Ratio (2021 - 2025)
Bioregenx (BRGX) has 5 years of Equity Ratio data on record, last reported at 3.12 in Q3 2025.
- For Q3 2025, Equity Ratio fell 499.85% year-over-year to 3.12; the TTM value through Sep 2025 reached 3.12, down 499.85%, while the annual FY2024 figure was 6.65, 177.73% down from the prior year.
- Equity Ratio reached 3.12 in Q3 2025 per BRGX's latest filing, up from 3.18 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.81 in Q1 2024 and bottomed at 82.34 in Q3 2023.
- Average Equity Ratio over 5 years is 15.94, with a median of 3.18 recorded in 2025.
- Peak YoY movement for Equity Ratio: tumbled 6382.36% in 2022, then skyrocketed 102.63% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.66 in 2021, then plummeted by 6382.36% to 42.74 in 2022, then surged by 94.4% to 2.39 in 2023, then tumbled by 177.73% to 6.65 in 2024, then surged by 53.0% to 3.12 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 3.12 in Q3 2025, 3.18 in Q2 2025, and 7.37 in Q1 2025.